Analyses of liver-specific miRNA function and the development of the strategy about the efficient induction of differentiation into hepatocytes
Project/Area Number |
22590718
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Gastroenterology
|
Research Institution | The University of Tokyo |
Principal Investigator |
KONDO Yuuji 東京大学, 医学部附属病院, 助教 (00572231)
|
Co-Investigator(Kenkyū-buntansha) |
吉田 晴彦 東京大学, 医学部附属病院, 講師 (60240305)
大塚 基之 東京大学, 医学部附属病院, 助教 (90518945)
|
Project Period (FY) |
2010 – 2012
|
Project Status |
Completed (Fiscal Year 2012)
|
Budget Amount *help |
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2012: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2011: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2010: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Keywords | 肝臓学 / microRNA / 分化 / 肝細胞 / 肝癌 / AFP / microRNA122 / 癌幹細胞 / 肝細胞癌 |
Research Abstract |
Liver specific miR122 is frequently downregulated in hepatocellular carcinoma (HCC). Knockdown of miR122 induces AFP expression, indicating the de-differentiation of hepatocytes. Decreased miR122 expression leads to the increased expression of CUX1, a transcriptional factor, which is related with the aggressiveness of HCC. From these results, decreased miR122 results in the AFP expression and aggressiveness of HCC, which is a molecular explanation about the clinical poor prognosis of HCCs with high AFP expression.
|
Report
(4 results)
Research Products
(17 results)
-
-
-
-
[Journal Article] MicroRNA122 is a key regulator of alpha-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma.2011
Author(s)
Kojima K, Takata A, Vadnais C, Otsuka M, Yoshikawa T, Akanuma M, Kondo Y, Kang YJ, Kishikawa T, Kato N, Xie Z, Zhang WJ, Yoshida H,Omata M, Nepveu A, Koike K.
-
Journal Title
Nat Commun
Volume: 2
Pages: 338-338
Related Report
Peer Reviewed
-
[Journal Article] Intrahepatic bile ductdilatation after percutaneous radiofrequency ablation for hepatocellular carcinoma: impact on patient's prognosis.2011
Author(s)
Kondo Y, Shiina S, Tateishi R, Arano T, Uchino K, Enooku K, Goto E, Nakagawa H, Masuzaki R, Asaoka Y, Fujie H, Goto T, Omata M, Yoshida H, Koike K.
-
Journal Title
Liver Int
Volume: 31
Pages: 197-205
Related Report
Peer Reviewed
-
[Journal Article] MicroRNA122 is a key regulator of alpha-fetoprotein expression and influences the aggressiveness of hepatocellular carcinoma2011
Author(s)
Kojima K, Takata A, Vadnais C, Otsuka M, Yoshikawa T, Akanuma M, Kondo Y, Kang YJ, Kishikawa T, Kato N, Xie Z, Zhang WJ, Yoshida H, Omata M, Nepveu A, Koike K
-
Journal Title
Nat Commun.
Volume: 2
Issue: 1
Pages: 338-338
DOI
Related Report
Peer Reviewed
-
[Journal Article] Intrahepatic bile duct dilatation after percutaneous radiofrequency ablation for hepatocellular carcinoma: impact on patient's prognosis.2011
Author(s)
Kondo Y, Shiina S, Tateishi R, Arano T, Uchino K, Enooku K, Goto E, Nakagawa H, Masuzaki R, Asaoka Y, Fujie H, Goto T, Omata M, Yoshida H, Koike K.
-
Journal Title
Liver Int
Volume: 31(2)
Issue: 2
Pages: 197-205
DOI
Related Report
Peer Reviewed
-
[Journal Article] Prediction of hepatocellular carcinoma development by plasma ADAMTS 13 in chronic hepatitis B and C2011
Author(s)
Ikeda H, Tateishi R, Enooku K, Yoshida H, nakagawa H, Masuzaki R, Kondo Y, Goto T, Shiina S, Kume Y, Tomiya T, Inoue Y, Nishikawa T, Ohtomo N, Tanoue Y, Ono T, Koike K, Yatomi Y
-
Journal Title
Cancer Epidemiol Biomarkers Prev.
Volume: 20
Issue: 10
Pages: 2204-11
DOI
Related Report
Peer Reviewed
-
[Journal Article] Serum level of adiponectin and the risk of liver cancer development in chronic hepatitis C patients.2011
Author(s)
Arano T, Nakagawa H, Tateishi R, Ikeda H, Uchino K, Enooku K, Goto E, Masuzaki R, Asaoka Y, Kondo Y, Goto T, Shiina S, Omata M, Yoshida H, Koike K.
-
Journal Title
Int J Cancer.
Volume: (In press)(掲載確定)
Related Report
Peer Reviewed
-
[Journal Article] Intrahepatic bile duct dilatation after percutaneous radiofrequency ablation for hepatocellular carcinoma : impact on patient's prognosis.2011
Author(s)
Koncro Y, Shiina S, Tateishi R, Arano T, Uchino K, Enooku K, Goto E, Nakagawa H, Masuzaki R, Asaoka Y, Fujie H, Goto T, Omata M, Yoshida H, Koike K.
-
Journal Title
Liver Int.
Volume: (In press)(掲載確定)
Pages: 197-205
Related Report
Peer Reviewed
-
[Journal Article] A phise I/II trial of the oral antiangiogenic agent TSU-68 in patients with advanced hepatocellular carcinoma.2011
Author(s)
Kanai F, Yoshida H, Tateishi R, Sato S, Kawabe T, Obi S, Kondo Y, Taniguchi M, Tagawa K, Ikeda M, Morizane C, Okusaka T, Arioka H, Shiina S, Omata M.
-
Journal Title
Cancer Chemother Pharmacol.
Volume: (In press)(掲載確定)
Pages: 315-24
Related Report
Peer Reviewed
-
-
-
-
-
-